Display options
Cite
Kantak KM, Miczek KA. Social, motor, and autonomic signs of morphine withdrawal: differential sensitivities to catecholaminergic drugs in mice. Psychopharmacology (Berl). 1988;96(4):468-76doi: 10.1007/BF02180026.
Kantak, K. M., & Miczek, K. A. (1988). Social, motor, and autonomic signs of morphine withdrawal: differential sensitivities to catecholaminergic drugs in mice. Psychopharmacology, 96(4), 468-76. https://doi.org/10.1007/BF02180026
Kantak, K M, and Miczek, K A. "Social, motor, and autonomic signs of morphine withdrawal: differential sensitivities to catecholaminergic drugs in mice." Psychopharmacology vol. 96,4 (1988): 468-76. doi: https://doi.org/10.1007/BF02180026
Kantak KM, Miczek KA. Social, motor, and autonomic signs of morphine withdrawal: differential sensitivities to catecholaminergic drugs in mice. Psychopharmacology (Berl). 1988;96(4):468-76. doi: 10.1007/BF02180026. PMID: 3149768.
Copy Download .nbib Format: NLM
Share it on

Psychopharmacology (Berl). 1988;96(4):468-76. doi: 10.1007/BF02180026.

Social, motor, and autonomic signs of morphine withdrawal: differential sensitivities to catecholaminergic drugs in mice.

Psychopharmacology

K M Kantak, K A Miczek

Affiliations

  1. Department of Psychology, Tufts University, Medford, MA 02155.

PMID: 3149768 DOI: 10.1007/BF02180026

Abstract

Drugs that predominantly influence catecholamines were used in order to simultaneously determine their ability to alter salient signs of social, motor and autonomic activity during morphine withdrawal, and to compare the sensitivity of each of these signs to these drugs. Cocaine, d-amphetamine, apomorphine and L-dopa increased attack and threat, but did not induce defensive behavior in morphine-withdrawn resident mice who were more responsive to the aggression-enhancing effects of these drugs than placebo control mice. Concurrently measured withdrawal jumping was not affected by these drugs, and the sensitivity to the hypothermic effects of these drugs was reduced. In contrast, clonidine decreased attack and threat behaviors, and morphine-withdrawn mice were more sensitive to this inhibitory influence. But like the stimulant drugs, clonidine did not affect withdrawal jumping, and the hypothermic action of clonidine was attenuated in morphine-withdrawn mice. These findings show that in mice, opiate withdrawal leads to altered attack and threat that is further amplified by catecholaminergic drugs. The present pattern of results indicates differential drug effects on social, motor and autonomic functions when the behaviors are measured 48 h following withdrawal.

Cited by

References

  1. J Pharmacol Exp Ther. 1976 Mar;196(3):637-41 - PubMed
  2. Psychopharmacology (Berl). 1983;81(4):286-91 - PubMed
  3. Psychopharmacol Commun. 1976;2(2):165-71 - PubMed
  4. Adv Pharmacol. 1967;5:79-108 - PubMed
  5. Am J Psychol. 1968 Sep;81(3):439-42 - PubMed
  6. Br J Pharmacol. 1979 Mar;65(3):525-33 - PubMed
  7. Psychopharmacologia. 1974;39(2):121-43 - PubMed
  8. Science. 1982 Mar 26;215(4540):1643-5 - PubMed
  9. Psychopharmacologia. 1963 May 21;4:247-60 - PubMed
  10. Brain Res. 1977 Nov 18;136(3):570-7 - PubMed
  11. Eur J Pharmacol. 1975 Mar;31(1):81-93 - PubMed
  12. Pharmacol Biochem Behav. 1982 Feb;16(2):359-60 - PubMed
  13. Psychopharmacology (Berl). 1979 Jan 31;60(2):165-72 - PubMed
  14. Psychopharmacologia. 1975 Jul 23;43(1):43-6 - PubMed
  15. Psychopharmacology (Berl). 1981;74(3):271-4 - PubMed
  16. J Pharmacol Exp Ther. 1969 May;167(1):1-8 - PubMed
  17. Psychopharmacologia. 1971;22(3):217-23 - PubMed
  18. J Pharmacol Exp Ther. 1973 Feb;184(2):398-403 - PubMed
  19. Prog Clin Biol Res. 1981;71:243-58 - PubMed
  20. NIDA Res Monogr. 1979;27:36-47 - PubMed
  21. Eur J Pharmacol. 1975 Jan;30(1):93-9 - PubMed
  22. Life Sci. 1975 Jul 1;17(1):29-34 - PubMed
  23. J Pharmacol Exp Ther. 1980 May;213(2):273-83 - PubMed
  24. Psychopharmacologia. 1974 Apr 23;36(3):189-202 - PubMed
  25. Pharmacol Biochem Behav. 1985 Dec;23(6):1059-63 - PubMed
  26. Psychopharmacologia. 1976;46(1):41-51 - PubMed
  27. Nature. 1972 May 26;237(5352):220-3 - PubMed
  28. J Pharmacol Exp Ther. 1982 Mar;220(3):464-7 - PubMed
  29. Neuropharmacology. 1982 Jul;21(7):711-3 - PubMed
  30. Psychopharmacology (Berl). 1978 Apr 14;57(1):47-55 - PubMed
  31. J Pharmacol Exp Ther. 1973 Feb;184(2):404-8 - PubMed
  32. Psychopharmacologia. 1973 Oct 23;33(1):19-38 - PubMed
  33. Psychopharmacology (Berl). 1986;90(4):451-6 - PubMed
  34. Pharmacol Biochem Behav. 1981;14 Suppl 1:53-9 - PubMed
  35. Psychopharmacologia. 1974 Jan 9;34(1):37-44 - PubMed
  36. Neuropharmacology. 1974 Feb;13(2):119-28 - PubMed
  37. Annu Rev Neurosci. 1984;7:443-78 - PubMed
  38. Psychopharmacologia. 1973;32(2):113-20 - PubMed
  39. Psychopharmacology (Berl). 1986;88(3):392-7 - PubMed
  40. Br J Pharmacol. 1969 Feb;35(2):253-64 - PubMed

Substances

MeSH terms

Publication Types

Grant support